Literature DB >> 15037318

Craniofacial defects in mice lacking BMP type I receptor Alk2 in neural crest cells.

Marek Dudas1, Somyoth Sridurongrit, Andre Nagy, Kenji Okazaki, Vesa Kaartinen.   

Abstract

Neural crest cells (NCCs) are pluripotent migratory cells that contribute to the development of various craniofacial structures. Many signaling molecules have been implicated in the formation, migration and differentiation of NCCs including bone morphogenetic proteins (BMPs). BMPs signal through a receptor complex composed of type I and type II receptors. Type I receptors (Alk2, Alk3 and Alk6) are the primary determinants of signaling specificity and therefore understanding their function is important in revealing the developmental roles of molecular pathways regulated by BMPs. Here we used a Cre/loxP system for neural crest specific deletion of Alk2. Our results show that mice lacking Alk2 in the neural crest display multiple craniofacial defects including cleft palate and a hypotrophic mandible. Based on the present results we conclude that signaling via Alk2 receptors is non-redundant and regulates normal development of a restricted set of structures derived from the cranial neural crest.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037318     DOI: 10.1016/j.mod.2003.12.003

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  106 in total

1.  Distinctive role of ACVR1 in dentin formation: requirement for dentin thickness in molars and prevention of osteodentin formation in incisors of mice.

Authors:  Xue Zhang; Ce Shi; Huan Zhao; Yijun Zhou; Yue Hu; Guangxing Yan; Cangwei Liu; Daowei Li; Xinqing Hao; Yuji Mishina; Qilin Liu; Hongchen Sun
Journal:  J Mol Histol       Date:  2018-12-05       Impact factor: 2.611

2.  Trigenic neural crest-restricted Smad7 over-expression results in congenital craniofacial and cardiovascular defects.

Authors:  Sunyong Tang; Paige Snider; Antony B Firulli; Simon J Conway
Journal:  Dev Biol       Date:  2010-05-08       Impact factor: 3.582

3.  Fibrodysplasia ossificans progressiva: a human genetic disorder of extraskeletal bone formation, or--how does one tissue become another?

Authors:  Eileen M Shore
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012 Jan-Feb       Impact factor: 5.814

4.  Developmental microRNA expression profiling of murine embryonic orofacial tissue.

Authors:  Partha Mukhopadhyay; Guy Brock; Vasyl Pihur; Cynthia Webb; M Michele Pisano; Robert M Greene
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-07

5.  Modulation of BMP signaling by Noggin is required for the maintenance of palatal epithelial integrity during palatogenesis.

Authors:  Fenglei He; Wei Xiong; Ying Wang; Maiko Matsui; Xueyan Yu; Yang Chai; John Klingensmith; Yiping Chen
Journal:  Dev Biol       Date:  2010-08-19       Impact factor: 3.582

6.  Bmpr1a signaling plays critical roles in palatal shelf growth and palatal bone formation.

Authors:  Jin-A Baek; Yu Lan; Han Liu; Kathleen M Maltby; Yuji Mishina; Rulang Jiang
Journal:  Dev Biol       Date:  2010-12-23       Impact factor: 3.582

7.  BMP type I receptor ALK2 is essential for proper patterning at late gastrulation during mouse embryogenesis.

Authors:  Yoshihiro Komatsu; Gregory Scott; Andre Nagy; Vesa Kaartinen; Yuji Mishina
Journal:  Dev Dyn       Date:  2007-02       Impact factor: 3.780

8.  Prdm16 is required for normal palatogenesis in mice.

Authors:  Bryan C Bjork; Annick Turbe-Doan; Mary Prysak; Bruce J Herron; David R Beier
Journal:  Hum Mol Genet       Date:  2009-12-11       Impact factor: 6.150

9.  Prx1 and Prx2 cooperatively regulate the morphogenesis of the medial region of the mandibular process.

Authors:  Anamaria Balic; Douglas Adams; Mina Mina
Journal:  Dev Dyn       Date:  2009-10       Impact factor: 3.780

10.  Functions of the type 1 BMP receptor Acvr1 (Alk2) in lens development: cell proliferation, terminal differentiation, and survival.

Authors:  Ramya Rajagopal; Lisa K Dattilo; Vesa Kaartinen; Chu-Xia Deng; Lieve Umans; An Zwijsen; Anita B Roberts; Erwin P Bottinger; David C Beebe
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-19       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.